Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 15 October 2002
Vol. 2002, Issue 154, p. tw375
[DOI: 10.1126/stke.2002.154.tw375]

EDITORS' CHOICE

Neurobiology An Inhibitory Approach to Parkinson's Disease

Individuals with Parkinson's disease have trouble walking and show pronounced hand tremor because the movement-controlling servomechanism in the brain loses the dopamine-containing cells of the subtantia nigra. Luo et al. now suggest a possible compensatory approach to therapy for this disease. The authors injected viral vectors containing the genes for glutamic acid decarboxylase (the enzyme that makes the inhibitory neurotransmitter {gamma}-aminobutyric acid (GABA) into the subthalamic nucleus of rats with artificially created Parkinson's symptoms. The overexcitatory cells in this nucleus also produced inhibition and so reduced the abnormal excitatory drive to the substantia nigra. The rats showed improvement in their Parkinson's-like disorder, and their dopamine-containing cells were protected from damage caused by further insult.

J. Luo, M. G. Kaplitt, H. L. Fitzsimons, D. S. Zuzga, Y. Liu, M. L. Oshinsky, M. J. During, Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 298, 425-429 (2002). [Abstract] [Full Text]

Citation: An Inhibitory Approach to Parkinson's Disease. Sci. STKE 2002, tw375 (2002).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882